{
    "2021-03-21": [
        [
            {
                "time": "",
                "original_text": "华大智造首回科创板IPO问询补充披露的这一非关联方数据亮了",
                "features": {
                    "keywords": [
                        "华大智造",
                        "科创板",
                        "IPO",
                        "问询",
                        "补充披露",
                        "非关联方",
                        "数据"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "警惕！市场猛烈砸盘，下周解禁股名单来了！医药大牛股赫然在列（附股） 解禁",
                "features": {
                    "keywords": [
                        "市场",
                        "砸盘",
                        "解禁股",
                        "医药",
                        "大牛股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "惊雷！市场猛砸盘，定增热门龙头股，高瓴亏损超3亿元，网友：抄底的机会来了？下周解禁股名单来了，医药大牛股赫然在列（附股） 亏损",
                "features": {
                    "keywords": [
                        "市场",
                        "砸盘",
                        "定增",
                        "龙头股",
                        "高瓴",
                        "亏损",
                        "解禁股",
                        "医药",
                        "大牛股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "投资机构"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}